Literature DB >> 9658081

Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway.

W Popik1, J E Hesselgesser, P M Pitha.   

Abstract

We have previously shown that binding of human immunodeficiency virus type 1 (HIV-1) virions to CD4 receptors stimulates association of Lck with Raf-1 and results in the activation of Raf-1 kinase in a Ras-independent manner. In the present study, we demonstrate that HIV-1 envelope glycoproteins of both T-cell-tropic and macrophagetropic strains rapidly activate the ERK/mitogen-activated protein (MAP) kinase pathway and the binding of nuclear transcription factors (AP-1, NF-kappaB, and C/EBP) and stimulate expression of cytokine and chemokine genes. The activation of this signaling pathway requires functional CD4 receptors and is independent of binding to CXCR4. Binding of the natural ligand stromal cell-derived factor 1 (SDF-1) to CXCR4, which inhibits entry of T-cell-tropic HIV-1, activates also the ERK/MAP kinase pathway. However, SDF-1 did not affect the CD4-mediated expression of cytokine and chemokine genes. These results provide firm molecular evidence that binding of HIV-1 envelope glycoproteins to CD4 receptor initiates a signaling pathway(s) independent of the binding to the chemokine receptor that leads to the aberrant expression of inflammatory genes and may contribute significantly to HIV-1 replication as well as to deregulation of the immune system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9658081      PMCID: PMC109793     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  The role of mononuclear phagocytes in HTLV-III/LAV infection.

Authors:  S Gartner; P Markovits; D M Markovitz; M H Kaplan; R C Gallo; M Popovic
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

2.  Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lck.

Authors:  A Veillette; M A Bookman; E M Horak; L E Samelson; J B Bolen
Journal:  Nature       Date:  1989-03-16       Impact factor: 49.962

3.  Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes.

Authors:  D Emilie; M Peuchmaur; M C Maillot; M C Crevon; N Brousse; J F Delfraissy; J Dormont; P Galanaud
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

4.  Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.

Authors:  E S Rosenberg; J M Billingsley; A M Caliendo; S L Boswell; P E Sax; S A Kalams; B D Walker
Journal:  Science       Date:  1997-11-21       Impact factor: 47.728

5.  Inhibition by interferon of herpes simplex virus type 1-activated transcription of tat-defective provirus.

Authors:  W Popik; P M Pitha
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

6.  Infection with HIV is associated with elevated IL-6 levels and production.

Authors:  E C Breen; A R Rezai; K Nakajima; G N Beall; R T Mitsuyasu; T Hirano; T Kishimoto; O Martinez-Maza
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

7.  Human immunodeficiency virus type 1 envelope glycoproteins gp120 and gp160 induce interleukin-6 production in CD4+ T-cell clones.

Authors:  N Oyaizu; N Chirmule; Y Ohnishi; V S Kalyanaraman; S Pahwa
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

8.  Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome.

Authors:  J Lähdevirta; C P Maury; A M Teppo; H Repo
Journal:  Am J Med       Date:  1988-09       Impact factor: 4.965

9.  Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines.

Authors:  L Buonaguro; G Barillari; H K Chang; C A Bohan; V Kao; R Morgan; R C Gallo; B Ensoli
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Interferon-gamma concentrations are increased in sera from individuals infected with human immunodeficiency virus type 1.

Authors:  D Fuchs; A Hausen; G Reibnegger; E R Werner; G Werner-Felmayer; M P Dierich; H Wachter
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989
View more
  74 in total

Review 1.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

2.  Activation of NF-kappaB by R5 and X4 human immunodeficiency virus type 1 induces macrophage inflammatory protein 1alpha and tumor necrosis factor alpha in macrophages.

Authors:  Wonkyu Choe; David J Volsky; Mary Jane Potash
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

3.  Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes.

Authors:  S Neil; F Martin; Y Ikeda; M Collins
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway.

Authors:  Nancy Q Liu; Albert S Lossinsky; Waldemar Popik; Xia Li; Chandrasekhar Gujuluva; Benjamin Kriederman; Jaclyn Roberts; Tatania Pushkarsky; Michael Bukrinsky; Marlys Witte; Martin Weinand; Milan Fiala
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

Review 5.  Signaling through the P38 and ERK pathways: a common link between HIV replication and the immune response.

Authors:  Robert L Furler; Christel H Uittenbogaart
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

6.  The Src kinase Lyn is required for CCR5 signaling in response to MIP-1beta and R5 HIV-1 gp120 in human macrophages.

Authors:  Brian Tomkowicz; Chuhee Lee; Vipa Ravyn; Ricky Cheung; Andrzej Ptasznik; Ronald G Collman
Journal:  Blood       Date:  2006-04-18       Impact factor: 22.113

7.  Myeloid Dendritic Cells Induce HIV Latency in Proliferating CD4+ T Cells.

Authors:  Nitasha A Kumar; Renee M van der Sluis; Talia Mota; Rachel Pascoe; Vanessa A Evans; Sharon R Lewin; Paul U Cameron
Journal:  J Immunol       Date:  2018-07-20       Impact factor: 5.422

8.  Induction of rapid and extensive beta-chemokine synthesis in macrophages by human immunodeficiency virus type 1 and gp120, independently of their coreceptor phenotype.

Authors:  W Choe; D J Volsky; M J Potash
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells.

Authors:  Madhavan P N Nair; Zainulabedin M Saiyed; Narayanan Nair; Nimisha H Gandhi; Jose W Rodriguez; Nawal Boukli; Elias Provencio-Vasquez; Robert M Malow; Maria Jose Miguez-Burbano
Journal:  J Neuroimmune Pharmacol       Date:  2008-10-29       Impact factor: 4.147

10.  Phosphatidylcholine-specific phospholipase C activation is required for CCR5-dependent, NF-kB-driven CCL2 secretion elicited in response to HIV-1 gp120 in human primary macrophages.

Authors:  Laura Fantuzzi; Francesca Spadaro; Cristina Purificato; Serena Cecchetti; Franca Podo; Filippo Belardelli; Sandra Gessani; Carlo Ramoni
Journal:  Blood       Date:  2008-01-18       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.